ABSTRACT NUMBER: ESOC2026A1875 ASSOCIATION OF CORTICAL VENOUS OPACIFICATION PATTERNS AND OUTCOMES IN PATIENTS WITH TANDEM CAROTID OCCLUSION FROM THE ACT TRIAL

Abstract Background and aims Cortical venous opacification may reflect ischemic severity in large vessel occlusion (LVO) strokes, but its association with outcomes in tandem occlusion (cervical ICA occlusion with concurrent intracranial ICA, M1, or M2 occlusion) is unclear. Methods We performed a post-hoc analysis of the alteplase compared to tenecteplase (AcT) trial. The sphenoparietal sinus, superficial middle cerebral vein, and vein of Labbé received a Cortical Venous Opacification Score (COVES) graded 0-2 on CTA (total 0–6: lower scores indicate poorer filling). COVES+ with the internal cerebral vein (total 0-8) was also assessed. Associations with functional and safety outcomes were evaluated using regression models adjusted for age, NIHSS, ASPECTS, and door-to-needle time. Results Among 127 patients with tandem occlusion (median age 69 [IQR 60–78] years; 32% female), 17 (13.4%) had a COVES of 0 and 110 (86.6%) had COVES >0. Compared to COVES >0, patients with COVES 0 had higher NIHSS (median 20 [IQR 18–22] vs 16 [IQR 10–20], p=0.002), lower ASPECTS (median 8 [range 4–10] vs 8 [range 5–10], p=0.031), and a higher proportion with poor collaterals (29.4% vs 8.2%). COVES score was not associated with 90-day functional outcomes (ordinal mRS: acOR 1.04 [95% CI 0.86-1.26]), mortality, or symptomatic intracranial hemorrhage. COVES+ also showed no associations with outcomes. Conclusions Cortical venous opacification was not associated with functional or safety outcomes in patients with tandem occlusion in the AcT trial. These findings may reflect the small sample size or differences from the broader LVO population, warranting further study. Conflict of interest CreeAnn Phillips: nothing to disclose, Nahal Farhani: nothing to disclose, Alexandre Poppe: nothing to disclose, Bijoy Menon:nothing to disclose, Nishita Singh: nothing to disclose, Fouzi Bala: nothing to disclose, Taha Aslan: nothing to disclose, Mohammed Almekhlafi: nothing to disclose, Katrina Ignacio: nothing to disclose.

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.883
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A1875 ASSOCIATION OF CORTICAL VENOUS OPACIFICATION PATTERNS AND OUTCOMES IN PATIENTS WITH TANDEM CAROTID OCCLUSION FROM THE ACT TRIAL

Taha Aslan, Nahal Farhani, Katrina Hannah Ignacio, Fouzi Bala et al.
European Stroke Journal
Acute Ischemic Stroke Management
article

ABSTRACT NUMBER: ESOC2026A1875 ASSOCIATION OF CORTICAL VENOUS OPACIFICATION PATTERNS AND OUTCOMES IN PATIENTS WITH TANDEM CAROTID OCCLUSION FROM THE ACT TRIAL

Taha Aslan, Nahal Farhani, Katrina Hannah Ignacio, Fouzi Bala, Bijoy Menon, Alexandre Y Poppe, Mohammed Almekhlafi, Nishita Singh, Creeann Phillips
article en

Abstract

Abstract Background and aims Cortical venous opacification may reflect ischemic severity in large vessel occlusion (LVO) strokes, but its association with outcomes in tandem occlusion (cervical ICA occlusion with concurrent intracranial ICA, M1, or M2 occlusion) is unclear. Methods We performed a post-hoc analysis of the alteplase compared to tenecteplase (AcT) trial. The sphenoparietal sinus, superficial middle cerebral vein, and vein of Labbé received a Cortical Venous Opacification Score (COVES) graded 0-2 on CTA (total 0–6: lower scores indicate poorer filling). COVES+ with the internal cerebral vein (total 0-8) was also assessed. Associations with functional and safety outcomes were evaluated using regression models adjusted for age, NIHSS, ASPECTS, and door-to-needle time. Results Among 127 patients with tandem occlusion (median age 69 [IQR 60–78] years; 32% female), 17 (13.4%) had a COVES of 0 and 110 (86.6%) had COVES >0. Compared to COVES >0, patients with COVES 0 had higher NIHSS (median 20 [IQR 18–22] vs 16 [IQR 10–20], p=0.002), lower ASPECTS (median 8 [range 4–10] vs 8 [range 5–10], p=0.031), and a higher proportion with poor collaterals (29.4% vs 8.2%). COVES score was not associated with 90-day functional outcomes (ordinal mRS: acOR 1.04 [95% CI 0.86-1.26]), mortality, or symptomatic intracranial hemorrhage. COVES+ also showed no associations with outcomes. Conclusions Cortical venous opacification was not associated with functional or safety outcomes in patients with tandem occlusion in the AcT trial. These findings may reflect the small sample size or differences from the broader LVO population, warranting further study. Conflict of interest CreeAnn Phillips: nothing to disclose, Nahal Farhani: nothing to disclose, Alexandre Poppe: nothing to disclose, Bijoy Menon:nothing to disclose, Nishita Singh: nothing to disclose, Fouzi Bala: nothing to disclose, Taha Aslan: nothing to disclose, Mohammed Almekhlafi: nothing to disclose, Katrina Ignacio: nothing to disclose.

European Stroke JournalVol. 11(Supplement_1)
Université de Tours (FR), University of Calgary (CA), Centre Hospitalier Universitaire de Tours (FR), University of Manitoba (CA), Université de Montréal (CA)
No poverty
Openalex Percentile: Top 9%
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.